This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Trading Volatile Big Pharma Stocks

NEW YORK ( TheStreet) -- To invest in any big pharmaceutical company, you must investigate the reasons to own each specific stock in terms of its drug pipeline, patent issues and potential FDA decisions on the use of new drug therapies.

Stock screening tools such as and the analysis of chart patterns cannot anticipate how a big pharma stock will react to a specific news release. ValuEngine data is based upon financial information based upon company filings. It is purely a quantitative analysis. Price charts for any stock measures the risk/reward for the ups and downs of the stock based upon price momentum and moving averages.

My proprietary analytics distill the tug of war between the oil of equity fundamentals and the water of technical analysis. My models calculate value levels, pivots and risky levels that buy-and-trade investors can us to buy on weakness and sell on strength. In developing this discipline I have assumed that nine years of price data has anticipated all potential bullish or bearish events for any market or stock.

If you know a big pharma company and what they do in the drug world you can maintain a core long position in the stock. Then you use ValuEngine ratings, simple moving averages and my proprietary analytics to add to positions on weakness and reduce positions on strength.

Stocks continue to trade under a ValuEngine valuation warning with 70.3% of all stocks overvalued, 33.7% overvalued by 20% or more. We still show that 15 of 16 sectors are overvalued, 12 by double-digit percentages including today's featured medical sector, which is overvalued by17.1%. The large cap pharma industry is 16.4% overvalued.

Among the 12 big pharma stocks in today's table four are undervalued and eight are overvalued with six overvalued by more than 20%. Ten stocks gained by 9.7% to 43.6% over the last 12 months with only two losing ground. The projected performances over the next 12 months range from a loss of 3.8% to a gain of 8.2%. The 12 month trailing price-to-earnings ratios show two stocks with single digit P/E and two with P/E above 20.0. Three stocks are below their 200-day simple moving averages, and nine are above, which indicates the risk of reversion to the mean.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABT $38.90 0.00%
AGN $216.56 0.00%
AZN $28.96 0.00%
BMY $72.18 0.00%
GSK $42.91 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs